Novel Therapeutic Targets:

In breast cancer research, scientists are constantly searching for new "targets" within cancer cells that can be treated with therapies. These targets are specific molecules or pathways that play a key role in cancer growth and spread. Identifying novel therapeutic targets helps develop treatments that can precisely attack cancer cells while sparing healthy tissue.

For instance, researchers are studying the PI3K/AKT/mTOR pathway, commonly altered in breast cancer, as a potential target for drugs. Another target is the HER2 protein, overexpressed in some breast cancers, leading to drugs like trastuzumab.

Emerging targets such as CDK4/6 inhibitors are showing promise, particularly in hormone receptor-positive breast cancer. By understanding these targets, scientists develop new drugs to block or interfere with them, disrupting cancer growth.

    Related Conference of Novel Therapeutic Targets:

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Novel Therapeutic Targets: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in